Cargando…

Reductions in circulating B cell subsets and immunoglobulin G levels with long-term belimumab treatment in patients with SLE

OBJECTIVE: To examine the long-term changes in circulating B cell subsets and IgG levels at 5+ years of continuous belimumab treatment and their correlations with efficacy and safety measures. METHODS: This was a post hoc analysis of a continuation study (BEL112233; NCT00724867) of eligible US patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Struemper, Herbert, Kurtinecz, Milena, Edwards, Lisa, Freimuth, William W, Roth, David A, Stohl, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Immunology and Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823257/ https://www.ncbi.nlm.nih.gov/pubmed/35131846 http://dx.doi.org/10.1136/lupus-2021-000499

Ejemplares similares

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus
por: Maeda, Shinji, et al.
Publicado: (2023)

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks
por: Neupane, Binod, et al.
Publicado: (2023)

Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
por: Maslen, Toni, et al.
Publicado: (2021)

Molecular endotypes of type 1 and type 2 SLE
por: Robl, Robert, et al.
Publicado: (2023)

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue
por: Åkesson, Karolina, et al.
Publicado: (2018)

Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
por: Dimelow, Richard, et al.
Publicado: (2020)

Surface complement C3 fragments and cellular binding of microparticles in patients with SLE
por: Winberg, Line Kjær, et al.
Publicado: (2017)

Population Pharmacokinetic and Pharmacodynamic Analysis of Belimumab Administered Subcutaneously in Healthy Volunteers and Patients with Systemic Lupus Erythematosus
por: Struemper, Herbert, et al.
Publicado: (2017)

L-sepiapterin restores SLE serum-induced markers of endothelial function in endothelial cells
por: Jones Buie, Joy N, et al.
Publicado: (2019)

The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps
por: Antiochos, Brendan, et al.
Publicado: (2022)

Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
por: Stockfelt, Marit, et al.
Publicado: (2021)

CD4(+) T-cell cooperation promoted pathogenic function of activated naïve B cells of patients with SLE
por: Wangriatisak, Kittikorn, et al.
Publicado: (2022)

Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study
por: Shao, Miao, et al.
Publicado: (2022)

The structures of secretory and dimeric immunoglobulin A
por: Kumar Bharathkar, Sonya, et al.
Publicado: (2020)

Differential accumulation of storage bodies with aging defines discrete subsets of microglia in the healthy brain
por: Burns, Jeremy Carlos, et al.
Publicado: (2020)

Functionally specialized human CD4(+) T-cell subsets express physicochemically distinct TCRs
por: Kasatskaya, Sofya A, et al.
Publicado: (2020)

Complex subsets but redundant clonality after B cells egress from spontaneous germinal centers
por: Castrillon, Carlos, et al.
Publicado: (2023)

The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets
por: Koike, Takuya, et al.
Publicado: (2019)

Gut Helicobacter presentation by multiple dendritic cell subsets enables context-specific regulatory T cell generation
por: Russler-Germain, Emilie V, et al.
Publicado: (2021)

Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
por: Sheikh, Saira Z., et al.
Publicado: (2016)

Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches
por: Asahi, Takuma, et al.
Publicado: (2023)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

Circulating T cell-monocyte complexes are markers of immune perturbations
por: Burel, Julie G, et al.
Publicado: (2019)

The effect of prolactin on immune cell subsets involved in SLE pathogenesis
por: Legorreta-Haquet, Maria Victoria, et al.
Publicado: (2022)

The HIV-1 latent reservoir is largely sensitive to circulating T cells
por: Warren, Joanna A, et al.
Publicado: (2020)

Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents
por: Wise, Leanna M., et al.
Publicado: (2020)

Small bowel stomas are associated with higher risk of circulating food-specific-IgG than patients with organic gastrointestinal conditions and colostomies
por: Carson, Walker K, et al.
Publicado: (2022)

Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases
por: Bi, Yanxia, et al.
Publicado: (2022)

Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program
por: Yapa, S Wickramaratne Senarath, et al.
Publicado: (2016)

Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer
por: Burfeind, Kevin G, et al.
Publicado: (2020)

Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data
por: D'Cruz, David, et al.
Publicado: (2023)

Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects
por: Struemper, Herbert, et al.
Publicado: (2015)

Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells
por: Laustsen, Anders, et al.
Publicado: (2021)

SLE - Systemic lupus erythematosus: a BLySful, yet BAFFling, disorder
por: Stohl, William
Publicado: (2003)

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
por: van Vollenhoven, Ronald F, et al.
Publicado: (2012)

Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation
por: Kolb, Philipp, et al.
Publicado: (2021)

Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports
por: Petri, Michelle, et al.
Publicado: (2023)

Analysis of allelic cross-reactivity of monoclonal IgG antibodies by a multiplexed reverse FluoroSpot assay
por: Hoffmann-Veltung, Henriette, et al.
Publicado: (2022)

KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides
por: Ficarelli, Mattia, et al.
Publicado: (2019)

Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care
por: Bruce, I N, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e74bjclne2d1sf1mht8imjq347